Screening & Diagnostics

Insights and analysis on screening and diagnostic technologies shaping modern healthcare. This category covers disease screening programs, diagnostic imaging, in vitro diagnostics, point of care testing, pathology solutions, and early detection tools used across hospitals, labs, and preventive care settings. Content focuses on market trends, technology innovation, regulatory developments, and global adoption patterns.

China Cancer Screening Market growth trends 2024 to 2033 forecast analysis

China Cancer Screening Market: Growth Trends, Forecast and Strategic Insights 2033

Introduction The China Cancer Screening Market is rapidly transforming as the country strengthens its healthcare infrastructure and shifts toward early detection and preventive care. With a growing burden of cancer cases and increasing awareness among the population, the China Cancer Screening Market is becoming a central pillar of China’s healthcare strategy. The expansion of screening […]

China Cancer Screening Market: Growth Trends, Forecast and Strategic Insights 2033 Read More »

Cancer Screening Market 2026 growth trends liquid biopsy molecular diagnostics global insights

Cancer Screening Market 2026: Growth Trends, Technology Evolution and Global Opportunities

Introduction to the Cancer Screening Market The cancer screening market has become one of the most critical pillars of modern healthcare systems as the global focus continues to shift toward prevention, early detection, and cost-effective disease management. Cancer remains a leading cause of death worldwide, and its growing incidence has intensified the need for reliable

Cancer Screening Market 2026: Growth Trends, Technology Evolution and Global Opportunities Read More »

Abbott Exact Sciences acquisition infographic showing cancer diagnostics molecular testing and early detection market impact

Abbott Acquires Exact Sciences: 7 Major Market Shifts

Abbott Exact Sciences Acquisition Reshapes Diagnostics Market The Abbott Exact Sciences acquisition is emerging as one of the most strategic developments in the global diagnostics industry. Abbott Laboratories expanding into advanced cancer screening through Exact Sciences Corporation signals a strong shift toward early disease detection and precision diagnostics. This move aligns with broader healthcare trends

Abbott Acquires Exact Sciences: 7 Major Market Shifts Read More »

AI based pathology and lab equipment 2026 featuring smart microscopes, automated lab machines, AI data analysis systems, and digital pathology technology in a modern medical laboratory environment.

AI Based Pathology and Lab Equipment 2026 Smart Diagnostic Workflow Shift

Analysis India: AI Based Pathology and Lab Equipment are becoming a defining force in modern healthcare in 2026 as laboratories focus on improving diagnostic speed, accuracy, and operational efficiency. These advanced systems use artificial intelligence to analyse blood, tissue, and cellular samples with high precision. Automated microscopes, digital pathology scanners, and smart lab analysers now

AI Based Pathology and Lab Equipment 2026 Smart Diagnostic Workflow Shift Read More »

Home diagnostic and point of care devices for smart healthcare testing

Home Diagnostic and Point of Care Devices: 2026 Smart Testing Shift

Analysis India: Home diagnostic and point of care devices are becoming a major pillar of modern healthcare in 2026 as testing continues to move closer to patients. Home diagnostic and point of care devices allow individuals to check important health indicators without visiting hospitals for routine tests. This shift is driven by rising demand for

Home Diagnostic and Point of Care Devices: 2026 Smart Testing Shift Read More »

×